Evidence map›Paper›PMID 35821150›Full record

ArticleAlzheimer's research & therapy2022

The impact of subthreshold levels of amyloid deposition on conversion to dementia in patients with amyloid-negative amnestic mild cognitive impairment.

Hyung-Ji Kim, Jungsu S Oh, Jae-Sung Lim, Sunju Lee, Sungyang Jo, E-Nae Chung, Woo-Hyun Shim, Minyoung Oh, Jae Seung Kim, Jee Hoon Roh and 2 more

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's research & therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. White matterAlzheimer's research & therapy · 2026
    Article
  2. Review
  3. Article
  4. Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  5. Association of precuneus Aβ burden with default mode network function.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Hyung-Ji KimDepartment of Neurology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
Jungsu S OhDepartment of Nuclear Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
Jae-Sung LimDepartment of Neurology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
Sunju LeeDepartment of Neurology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
Sungyang JoDepartment of Neurology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
E-Nae ChungHealth Innovation Bigdata Center, Asan Institute for Lifesciences, Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
Woo-Hyun ShimHealth Innovation Bigdata Center, Asan Institute for Lifesciences, Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
Minyoung OhDepartment of Nuclear Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
Jae Seung KimDepartment of Nuclear Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
Jee Hoon RohNeuroscience Institute, Korea University College of Medicine and School of Medicine, Seoul, South Korea.
Jae-Hong LeeDepartment of Neurology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea. jhlee@amc.seoul.kr.
Alzheimer’s Disease Neuroimaging Initiative
University of Ulsan · KRAsan Medical Center · KRKorea University · KRUlsan College · KR

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
NIA NIH HHS U01 AG024904
6 · The paper itself

Abstract

backgroundAbout 40-50% of patients with amnestic mild cognitive impairment (MCI) are found to have no significant Alzheimer's pathology based on amyloid PET positivity. Notably, conversion to dementia in this population is known to occur much less often than in amyloid-positive MCI. However, the relationship between MCI and brain amyloid deposition remains largely unknown. Therefore, we investigated the influence of subthreshold levels of amyloid deposition on conversion to dementia in amnestic MCI patients with negative amyloid PET scans.

methodsThis study was a retrospective cohort study of patients with amyloid-negative amnestic MCI who visited the memory clinic of Asan Medical Center. All participants underwent detailed neuropsychological testing, brain magnetic resonance imaging, and [

resultsDuring the follow-up period, 36% (39/107) of patients converted to dementia from amnestic MCI. The dementia converter group displayed increased standardized uptake value ratio (SUVR) values of FBB on PET in the bilateral temporal, parietal, posterior cingulate, occipital, and left precuneus cortices as well as increased global SUVR. Among volume of interests, the left parietal SUVR predicted conversion to dementia with the highest accuracy in the ROC analysis (area under the curve [AUC] = 0.762, P < 0.001). The combination of precuneus, parietal cortex, and FBB composite SUVRs also showed a higher accuracy in predicting conversion to dementia than other models (AUC = 0.763). Of the results of ADNI data, the SUVR of the left precuneus SUVR showed the highest AUC (AUC = 0.596, P = 0.006).

conclusionOur findings suggest that subthreshold amyloid levels may contribute to conversion to dementia in patients with amyloid-negative amnestic MCI.

Indexed as

Alzheimer DiseaseAmyloidosisCognitive DysfunctionActivities of Daily LivingAmyloidAmyloidogenic ProteinsDisease ProgressionHumansReproducibility of ResultsRetrospective StudiesAmyloidAmyloidogenic ProteinsAmyloidDementiaDisease progressionMild cognitive impairment

Identifiers

PMID35821150
PMCPMC9277922
OpenAlexW4285094744

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.